中国医学科学院学报

高级检索
中国医学科学院学报

中国医学科学院学报 ›› 2009, Vol. 31 ›› Issue (4): 389-392.doi: 10.3881/j.issn.1000-503X.2009.04.001

• 专家述评 •    下一篇

结核病的化学治疗及面临的挑战

马玙   

  1. 北京市结核病胸部肿瘤研究所结核科,北京 101149
  • 收稿日期:2009-05-14 修回日期:1900-01-01 出版日期:2009-08-30 发布日期:2009-08-30
  • 通讯作者: 马玙

Chemotherapy of Tuberculosis and Its Challenges

MA Yu   

  1. Department of Tuberculosis, Beijing Tuberculosis and Thoracic Tumor Research Institute,Beijing 101149,China
  • Received:2009-05-14 Revised:1900-01-01 Online:2009-08-30 Published:2009-08-30
  • Contact: MA Yu

摘要: 摘要:结核病是一种慢性传染病,是全球关注的公共卫生和社会问题。结核病疫情的下降缓慢、艾滋病流行、人类免疫缺陷病毒/结核病双重感染、耐多药/广泛耐药结核病的增多,对全球结核病控制规划的实施构成严重的威胁,对发展多年已趋成熟的结核病化疗无疑也是重大挑战。本文主要论述结核病化学治疗的发展与原则、结核病化学治疗面临的挑战及耐多药结核病的预防与治疗策略。

关键词: 耐多药结核病, 广泛耐药结核病, 化学治疗

Abstract: ABSTRACT:Tuberculosis (TB), a chronic communicable disease, continues to be a global public health concern. Slow decline of TB incidence and prevalence, human immunodeficiency virus/TB coinfection, growth of multidrug-resistant/extensively-resistant TB have made the control of TB even more challenging. Chemotherapy of TB has developed for decades and now also faces similar challenges.

Key words: multidruc-resistant tuberculosis, extensively-resistant tuberculosis, cdemotderapy